Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article posted on Market Watch referenced an article published in a May 2016 supplement to The American Journal of Managed Care® (AJMC®), titled “Economic Burden of Multiple Sclerosis and the Role of Managed Care Organizations in Multiple Sclerosis Management.” In assessing the burden of multiple sclerosis, researchers said treatment should be individualized, and shared decision-making between patients and health care providers must be preserved.
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More